Hexahydrocurcumin alleviated blood–brain barrier dysfunction in cerebral ischemia/reperfusion rats

© 2020, Maj Institute of Pharmacology Polish Academy of Sciences. Background: Hexahydrocurcumin (HHC), a major metabolite of curcumin, has been reported to have protective effects against ischemic and reperfusion damage. The goal of the present research was to examine whether HHC could alleviate bra...

Full description

Saved in:
Bibliographic Details
Main Authors: Piyawadee Wicha, Jiraporn Tocharus, Adchara Janyou, Jinatta Jittiwat, Waraluck Chaichompoo, Apichart Suksamrarn, Chainarong Tocharus
Format: Journal
Published: 2020
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85079642570&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/68572
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-68572
record_format dspace
spelling th-cmuir.6653943832-685722020-04-02T15:29:47Z Hexahydrocurcumin alleviated blood–brain barrier dysfunction in cerebral ischemia/reperfusion rats Piyawadee Wicha Jiraporn Tocharus Adchara Janyou Jinatta Jittiwat Waraluck Chaichompoo Apichart Suksamrarn Chainarong Tocharus Pharmacology, Toxicology and Pharmaceutics © 2020, Maj Institute of Pharmacology Polish Academy of Sciences. Background: Hexahydrocurcumin (HHC), a major metabolite of curcumin, has been reported to have protective effects against ischemic and reperfusion damage. The goal of the present research was to examine whether HHC could alleviate brain damage and ameliorate functional outcomes by diminishing the blood–brain barrier (BBB) damage that follows cerebral ischemia/reperfusion. Methods: Middle cerebral artery occlusion was induced for 2 h in rats followed by reperfusion. The rats were divided into three groups: sham-operated, vehicle-treated, and HHC-treated groups. At the onset of reperfusion, the rats were immediately intraperitoneally injected with 40 mg/kg HHC. At 48 h after reperfusion, the rats were evaluated for neurological deficits and TTC staining. At 24 h and 48 h after reperfusion, animals were sacrificed, and their brains were extracted. Results: Treatment with HHC reduced neurological scores, infarct volume, morphological changes, Evans blue leakage and immunoglobulin G extravasation. Moreover, HHC treatment reduced BBB damage and neutrophil infiltration, downregulated myeloperoxidase, ICAM-1, and VCAM-1, upregulated tight junction proteins (TJPs), and reduced aquaporin 4 expression and brain water content. Conclusion: These results revealed that HHC treatment preserved the BBB from cerebral ischemia/reperfusion injury by regulating TJPs, attenuating neutrophil infiltration, and reducing brain edema formation. Graphic abstract: [Figure not available: see fulltext.]. 2020-04-02T15:29:47Z 2020-04-02T15:29:47Z 2020-01-01 Journal 17341140 2-s2.0-85079642570 10.1007/s43440-019-00050-9 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85079642570&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/68572
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
topic Pharmacology, Toxicology and Pharmaceutics
spellingShingle Pharmacology, Toxicology and Pharmaceutics
Piyawadee Wicha
Jiraporn Tocharus
Adchara Janyou
Jinatta Jittiwat
Waraluck Chaichompoo
Apichart Suksamrarn
Chainarong Tocharus
Hexahydrocurcumin alleviated blood–brain barrier dysfunction in cerebral ischemia/reperfusion rats
description © 2020, Maj Institute of Pharmacology Polish Academy of Sciences. Background: Hexahydrocurcumin (HHC), a major metabolite of curcumin, has been reported to have protective effects against ischemic and reperfusion damage. The goal of the present research was to examine whether HHC could alleviate brain damage and ameliorate functional outcomes by diminishing the blood–brain barrier (BBB) damage that follows cerebral ischemia/reperfusion. Methods: Middle cerebral artery occlusion was induced for 2 h in rats followed by reperfusion. The rats were divided into three groups: sham-operated, vehicle-treated, and HHC-treated groups. At the onset of reperfusion, the rats were immediately intraperitoneally injected with 40 mg/kg HHC. At 48 h after reperfusion, the rats were evaluated for neurological deficits and TTC staining. At 24 h and 48 h after reperfusion, animals were sacrificed, and their brains were extracted. Results: Treatment with HHC reduced neurological scores, infarct volume, morphological changes, Evans blue leakage and immunoglobulin G extravasation. Moreover, HHC treatment reduced BBB damage and neutrophil infiltration, downregulated myeloperoxidase, ICAM-1, and VCAM-1, upregulated tight junction proteins (TJPs), and reduced aquaporin 4 expression and brain water content. Conclusion: These results revealed that HHC treatment preserved the BBB from cerebral ischemia/reperfusion injury by regulating TJPs, attenuating neutrophil infiltration, and reducing brain edema formation. Graphic abstract: [Figure not available: see fulltext.].
format Journal
author Piyawadee Wicha
Jiraporn Tocharus
Adchara Janyou
Jinatta Jittiwat
Waraluck Chaichompoo
Apichart Suksamrarn
Chainarong Tocharus
author_facet Piyawadee Wicha
Jiraporn Tocharus
Adchara Janyou
Jinatta Jittiwat
Waraluck Chaichompoo
Apichart Suksamrarn
Chainarong Tocharus
author_sort Piyawadee Wicha
title Hexahydrocurcumin alleviated blood–brain barrier dysfunction in cerebral ischemia/reperfusion rats
title_short Hexahydrocurcumin alleviated blood–brain barrier dysfunction in cerebral ischemia/reperfusion rats
title_full Hexahydrocurcumin alleviated blood–brain barrier dysfunction in cerebral ischemia/reperfusion rats
title_fullStr Hexahydrocurcumin alleviated blood–brain barrier dysfunction in cerebral ischemia/reperfusion rats
title_full_unstemmed Hexahydrocurcumin alleviated blood–brain barrier dysfunction in cerebral ischemia/reperfusion rats
title_sort hexahydrocurcumin alleviated blood–brain barrier dysfunction in cerebral ischemia/reperfusion rats
publishDate 2020
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85079642570&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/68572
_version_ 1681426844287500288